June 2026
The global autoimmune neurological disorders market size was evaluated at USD 8.50 billion in 2025 and is predicted to hit around USD 17.79 billion by 2035, growing at a CAGR of 7.90%.
June 2026
The global stem cell therapy for neurological disorders market size was evaluated at USD 2.38 billion in 2025 and is predicted to hit around USD 12.67 billion by 2035, growing at a CAGR of 17.90%.
September 2025
The U.S. digital health in neurology market size was evaluated at USD 13.32 billion in 2024 and is predicted to hit around USD 103.32 billion by 2034, growing at a CAGR of 22.73%.
August 2025
The neurotech devices market size was valued at USD 14.75 billion in 2024 and is projected to worth around USD 55.79 billion by 2034 with a CAGR of 13.84%.
July 2025
The neurology clinical trials market size was valued at USD 5.89 billion in 2024 and is projected to reach around USD 10.14 billion by 2034 with a CAGR of 5.58%.
June 2026
The global remote neurological monitoring market size was evaluated at USD 2.45 billion in 2025 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 14.80%.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 121.01 billion in 2025 with a CAGR of 6.07%.
June 2026
The global circadian rhythm sleep disorders market size was evaluated at USD 2.72 billion in 2025 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 6.80%.
May 2026
The neurological biomarkers market size reached USD 10.32 billion in 2025 and is projected to surpass around 34.02 billion by 2035, with a solid CAGR of 12.67%.
September 2025
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
August 2025
The global spinal imaging market size was calculated at USD 2.09 billion in 2024 and is predicted to attain around USD 3.49 billion by 2034, with a CAGR of 5.26%.
August 2025
The U.S. pantoprazole market size was evaluated at USD 743.96 million in 2024 and is predicted to hit around USD 1,302.87 million by 2034, growing at a CAGR of 5.76%.
August 2025
The global anti-thyroid peroxidase antibody test kit market size was valued at USD 150.07 million in 2024 and is expected to hit around USD 341.19 million by 2034, growing at a CAGR of 8.56%.
July 2025
The global bimekizumab (BIMZELX) market size was evaluated at USD 1.24 billion in 2024 and is predicted to hit around USD 8.10 billion by 2034, growing at a CAGR of 20.64%.
July 2025
The global fibrate drugs market size was valued at USD 3.42 billion in 2024 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
June 2025
The global artificial disc market size was evaluated at USD 2.23 billion in 2024 and is predicted to hit around USD 3.02 billion by 2034 with a CAGR of 3.08%.